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BacteriaDespite genetic variation has the potential to arise newprotein functions, spontaneousmutations usually destabilize
the native fold.Misfolded proteins tend to form cytotoxic intracellular aggregates, decreasing cellﬁtness and leading
to degenerative disorders in humans. Therefore, it is thought that selection against proteinmisfolding and aggrega-
tion constrains the evolution of protein sequences. However, obtaining experimental data to validate this hypothesis
has been traditionally difﬁcult. Herewe exploit bacteria as amodel organism to address this question. Using variants
of the Alzheimer's related Aβ42 peptide designed to exhibit different in vivo aggregation propensitieswe showhere
that, in cell competition experiments, themost aggregation-prone variants are always purged out from the growing
population. Flow cytometry analysis of cellular metabolism and viability demonstrates that this purifying effect re-
sponds to a clear correlation between physiological burden and intrinsic aggregation propensity. Interestingly, the
ﬁtness cost of aggregation appears to be associatedwith aggregation rates rather thanwith overall protein solubility.
Accordingly, we show that, by reducing in vivo aggregation rates, the model osmolyte proline is able to buffer the
metabolic impact of protein aggregation. Overall, our data provide experimental support for the role of toxic protein
aggregation on the cell ﬁtness landscape and the evolution of natural protein sequences.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Most genetic mutations decrease the probability of protein-coding se-
quences to pack into compact and stable conformations [1]. Protein
misfolding usually results in the formation of aggregates, which harms
cells and reduces ﬁtness [2]. In this way, protein aggregation is linked to
the onset of an increasing number of human degenerative disorders, in-
cluding Alzheimer's or Parkinson's diseases [3,4]. Protein aggregation is
a generic structural property of polypeptide chains that directly competes
with native protein folding [5,6]. Therefore, it might constrain the evolu-
tion of proteins, in such away that protein sequenceswould be shaped by
natural selection to encode polypeptides that would not aggregate at the
cellular concentrations and locations in which they should function [7,8],
the so-called “Life on the Edge”hypothesis [9]. This purifying effect of pro-
tein misfolding might explain why in all organisms, from bacteria to
humans, the speciﬁc rate of synonymous and non-synonymous substitu-
tions is slower in highly expressed proteins [10,11], since their mutation
will generate relatively more misfolded species.
Despite the deleterious effect of protein aggregation on cell physiol-
ogy is well documented [12,13], the magnitude of this effect has not
been sufﬁciently characterized experimentally. Quantiﬁcation of the in-
ﬂuence of genetic mutations on aggregation and ﬁtness is essential tooside; CTC, 5-cyano-2,3-ditolyl
FP, green ﬂuorescent protein;
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sequences and might also provide molecular mechanistic insights on
the basis of human conformational disorders [14]. However, quantifying
how sequential traits and the associated aggregation propensity impact
cellular metabolism and the cell ﬁtness landscape is a challenging task
because, in vivo, the intrinsic properties of proteins are modulated by
an array of different factors [15–17]. Bacterial systems provide simple
models to tackle this question under near-physiological conditions [18].
In bacteria, protein aggregation has been shown to impair cell division,
causing loss of cell reproductive ability or aging [19,20]. Importantly, the
aggregates formed by amyloidogenic proteins in bacteria share many
conformational propertieswith those causing disease [21–23]. In partic-
ular, we have shown previously that a fusion of the Alzheimer's related
Aβ42 peptide with GFP forms amyloid-like insoluble deposits when
expressed in bacteria and impairs cell division [20,24]. Here we used
thismodel system to address the relationship between protein aggrega-
tion propensity and protein evolution by analyzing the precise impact of
three designed Aβ42 variants differing in their in vivo aggregation prop-
erties on cell metabolism and viability using ﬂow cytometry and mea-
suring how these toxic effects correlate with the ﬁtness cost they
impose to the cell population.
2. Materials and methods
2.1. Bacterial strains and cell growth
Strains Escherichia coli BL21 DE3 transformed with pET-28a vec-
tor (Novagen, INC., Madison, WI) encoding for Aβ42wt-GFP (Green
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bically in liquid Luria–Bertani (LB) medium containing appropriate an-
tibiotics in a rotary shaker at 37 ºC and 250 rpm. Overnight cultures
were diluted 100-fold in LB and allowed to grow to an optical density
at 600 nm (OD600) of 0.5. At the indicated OD, protein expression was
induced with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and
0.5 M of osmolytes proline and trimethylamine n-oxide (TMAO) was
added, when necessary. Cultures were let to grow for 24 h.
2.2. Prediction of aggregation propensities
Theoretical aggregation-prone regions were predicted with TANGO
using the default settings [25].
2.3. Fluorescence measurements
After indicated incubation times, bacteria cells were harvested by
centrifugation andwashedwith phosphate-buffered saline (PBS buffer)
at pH 7.0. GFP ﬂuorescence in intact cells expressing the Aβ42wt-GFP,
F19D and F19D/L34P variantswasmeasured on a Jasco FP-8200 ﬂuores-
cence spectrophotometer (Jasco Corporation, Japan) in the 500–600 nm
range using an excitation wavelength of 470 nm.
2.4. Optical ﬂuorescence microscopy
10 μL of cultured cells was centrifuged andwashed in PBS buffer, and
deposited on top of glass slides. Images were obtained under UV light
using a ﬁlter for GFP excitation (450–500 nm) and an emission ﬁlter
(515–560 nm) in a Leica ﬂuorescence microscope (Leica Microsystems,
Germany).
2.5. Electrophoresis and immunoblots
E. coli cells expressing Aβ42wt-GFP, F19D and F19D/L34P variants
were lysed chemically. The cell lysate was centrifuged for 20 min at
12,000 g. The supernatant was collected separately and the pellet was
diluted in the same volume as supernantant. Samples of 10 μL of lysate
were separated on a 10% SDS-polyacrylamide gel electrophoresis
containing 0.1% SDS. Proteins were transferred to a polyvinylidene
diﬂuoride membrane (Immobilon, Millipore) with a Mini Trans-Blot
Cell (Bio-Rad). Membranes were blocked in 0.1 M Tris–HCl, pH 7.5,
0.5% Tween 20, 1% Triton X-100, 5% bovine serum albumin o/n and
probed for GFP expression using an anti-GFP antibody (Roche) diluted
1:1000 o/n in blocking solution. The secondary peroxidase-conjugated
antibody was goat anti-mouse IgG (BioRad) diluted 1:3000 in blocking
solution. Detection was carried out using an enhanced chemilumines-
cence (ECL) SuperSignal kit (Pierce).
2.6. Bacterial growth and preparation for ﬂow cytometry analysis
Overnight cultures of E. coli cells expressing Aβ42wt-GFP, F19D and
F19D/L34P mutants were diluted 100-fold in LB and allowed to grow to
an optical density at 600 nm (OD600) of 0.5. Then cultures were induced
with 1mM IPTG and samples were taken from exponential and station-
ary growth phases after 4, 8 and 24 h, respectively. Protein expression
levels were comparable among Aβ42-GFP variants in these conditions.
For analysis of osmolyte effects, proline and TMAO were added 30 min
before protein induction. Each sample was vortexed and diluted to an
OD of 0.2. Then diluted 10-fold in 0.22-μm ﬁltered PBS. Subsequently,
the cell suspension was centrifuged at 3500 g for 10 min, and the cells
were resuspended in 1 mL of PBS. All experiments were performed
using three biological replicates. Non-induced cultures of the three var-
iants were incubated and analyzed in the samemanner to serve as neg-
ative controls.2.7. IP staining
To analyze cell cultures viability, samples were stained with
propidium iodide (PI) dye (BD Biosciences) to a ﬁnal concentration of
50 μM in PBS. To prepare killed bacteria as a positive control, 1 mL of
sample was heated at 90 ºC for 10min prior to PI staining. The analyzed
data correspond to the bacteria population gated for SSC vs FITC-A so
that cell debris and non-intact cells were excluded from the analysis.
2.8. CTC staining
To evaluate the respiratory activity of E. coli cultures expressing
Aβ42wt-GFP, F19D and F19D/L34P mutants, cells were stained with 5-
cyano-2,3-ditolyl tetrazolium chloride (CTC) (Invitrogen). 1mL of dilut-
ed cells in PBS was treated with 100 μL of the 50 mM CTC working
solution, vortexed gently to mix and incubated for 30 min at 37 ºC,
protected from light.
2.9. Flow cytometry
Flow cytometrywas performed using a BD FACSCanto ﬂow cytometer
(BD Biosciences) equipped with 488 nm and 635 nm lasers. Cells were
ﬁrst gated (P1) by forward scatter (FSC) and side scatter (SCC) both set
on logarithmic ampliﬁcation. A threshold was set on FSC to reduce elec-
tronic background noise. Cells in P1 were then re-gated (P2) for green
ﬂuorescence emission (GFP) to separate bacterial cells from cellular de-
bris. GFP ﬂuorescence emission was measured on a 530/30 nm band
pass ﬁlter and CTC ﬂuorescence emission on a 670LP ﬁlter. All signals
were ampliﬁed. We acquired a total of 20,000 events logarithmically
(ﬁve decades). Data were acquired with the FACSDiva Software (BD
Biosciences). Data analysis was performed with the FlowJo software.
2.10. Competitive growth selection
Aβ42wt-GFP, F19D and F19D/L34P constructs were grown aerobi-
cally in LB medium containing 50 μg/mL kanamicin at 37 ºC and
250 rpm. The overnight cultureswere diluted 100-fold in a 50mL falcon
tube containing LB medium, 50 μg/mL kanamicin and 1 mM IPTG, and
allowed to grow at 37 ºC. At 8, 24 and 48 h harvest time, the DNA was
puriﬁed using the Plamid Miniprep kit (Thermo Scientiﬁc) following
themanufacturer instructions and sent for sequencing. Chromatograms
of the samples were analyzed with the software Sequence Scanner
(Applied Biosciences) to assign the dominant construct.
3. Results
3.1. Design of Aβ42 peptide variants displaying different aggregation
propensity
We have shown previously that the bacterial IBs formed by the
Alzheimer's disease-relatedAβ42 peptide display an amyloid-like struc-
ture when this peptide is expressed alone [22] or as a fusion to different
ﬂuorescent proteins [24]. We have constructed a library of 20 different
Aβ42-GFP mutants differing only in the residue in position 19 of the
Aβ42 peptide, which is a Phe residue in the wild type sequence [26].
All these fusions accumulate essentially in the insoluble cellular fraction.
However, the presence of active GFP in such aggregates differs signiﬁ-
cantly, displaying a high correlation with the aggregation propensity
of the Aβ42 mutants, due to the existence of an in vivo kinetic competi-
tion between the folding of the GFP domain and the aggregation of the
fusion protein, directed by the Aβmoiety [27]. The Asp mutant (F19D)
exhibited the slowest aggregation rate [28]. Here we wanted to further
increase this dynamic range and generate an Aβ42-GFP variant that not
onlywould aggregate slower than the F19Dmutant but would also shift
its solubility at equilibrium from beingmainly insoluble to mostly solu-
ble, while keeping changes to a minimum. An analysis of the Aβ42
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presence of twomain aggregation-prone stretches, comprising residues
17–21 and 30–41 (Fig. 1A); other predictors providing similar results
[30]. These programs coincide to indicate that the F19Dmutation abro-
gates the ﬁrst aggregation segment, but still the second and most im-
portant region remains intact. In the solid-state NMR structure of Aβ
amyloid ﬁbrils Phe19 in the ﬁrst β-strand interacts with Leu34 in the
second β-strand [31]. (Fig. 1B). Therefore, we analyzed the impact of
virtually mutating this residue to the rest of natural amino acids in the
F19D context. According to TANGO, the L34P mutation would have
the highest impact on the aggregation propensity of the peptide, strong-
ly reducing the area of the second aggregation prone region (Fig. 1A).
We proceed with the construction of the F19D/L34P double mutant
(Fig. 1C).
3.2. Solubility and ﬂuorescence of Aβ42 peptide variants
We expressed Aβ42wt-GFP as well as F19D and F19D/L34Pmutants
in E. coli and analyzed the distribution of the recombinant proteins be-
tween the soluble and insoluble fractions by western blotting. As previ-
ously reported [28], most of Aβ42wt (86%) and F19D (78%) variants
resided in the insoluble fraction (Fig. 2A). In contrast, as intended, ama-
jority of the F19D/L34P (73%)mutant turned to be soluble. It is worth to
note that the presence of SDS resistant high molecular weight bands,
likely corresponding to amyloid-like assemblies, is clearly observable
for the Aβ42wt, whereas these species are less evident and not observ-
able in the F19D and F19D/L34P variants, respectively.
Next, we measured the GFP ﬂuorescence of intact cells expressing
the three different variants using spectroﬂuorimetry. As shown in
Fig. 2B, the three mutants differ in their ﬂuorescence emission, cells ex-
pressing the F19D and F19D/L34P variants being three and seven-fold
more ﬂuorescent than cells expressing the Aβ42wt form, respectively.
We also assayed the GFP ﬂuorescence of the different cell populations
using ﬂow cytometry (FC) (Fig. 2C). The ability of FC to analyze a large
number of cells (20.000 cells/sample) averages experimental variability
and provides more quantitative results. The analysis indicates that,Fig. 1. Sequential properties of Aβ42 peptides. (a) Intrinsic aggregation propensity proﬁle of t
Aβ42-F19D/L34P are shown in red, green and blue, respectively. (b) Ribbon diagram of Aβ 3D
red, respectively. (c) Sequences of the Aβ42wt and the mutants in the present study.independently of the considered variant, a large majority of the cells
are ﬂuorescent indicating that they are expressing the correspondent
protein fusions. In good agreement with spectroﬂuorimetric data, the
mean ﬂuorescence values of cells expressing the F19D and the F19D/
L34P variants were around three (5457 ± 82) and seven (12963 ±
55) fold higher than these expressing Aβ42 (1924 ± 50), respectively.
Finally, we used ﬂuorescence microscopy to identify the cellular lo-
cation of the detected GFP emission (Fig. 2D). In good agreement with
fractionation analysis, in Aβ42wt and F19D, the ﬂuorescence is conﬁned
mainly in the IBs at the poles of the cells, the IBs of F19D being more
ﬂuorescent, as previously reported [32]. In contrast, the highest ﬂuores-
cence of F19D/L34P variant is homogeneously distributed in the cell
cytosol.
3.3. Relationship between Aβ42 aggregation propensity and cell death
Once we obtained three different variants of Aβ42 peptide ex-
hibiting a large dynamic range of in vivo aggregation propensities but
minimal sequential differences we were in conditions to study the im-
pact of aggregation propensity in cell viability. To this aim, cells contain-
ing the different Aβ42 variants were induced and their viability was
assessed 4, 8 and 24 h after induction of protein expression, using PI
staining, which only penetrates bacteria with damaged membranes,
by FC analysis. In a second channel we recorded simultaneously GFP
ﬂuorescence emission in such a way that dot plots of PI vs. GFP allows
to monitor both viable cells and their GFP ﬂuorescence gating bacteria
population in SSC-FSC plots; only intact cells displaying GFP ﬂuores-
cence and thus expressing the protein fusion were taken into account
for analysis (Fig. 3A). Non-induced cells were analyzed as negative con-
trols. Non-induced cells of the three variants exhibit very similar viabil-
ity with 98–100%, 97–99% and 94–97% of viable cells in the population
after 4, 8 and 24 h respectively (Fig. 3B).
For induced cells, the percentage of dead cells increases signiﬁcantly
with time for the three variants. However, at any time point we observe
a strict correlation between the aggregation propensity of the Aβ42 var-
iant and mortality (Fig. 3B). This relationship results in a qualitativehe different Aβ42 variants according to the TANGO algorithm. Aβ42wt, Aβ42-F19D, and
structure according to PDB: 2BEG with the side chains of F19 and L34 shown in blue and
Fig. 2. Intracellular aggregation properties of Aβ42 variants. (a) Immunoblot of SDS-PAGE of the total lysates (T) and the soluble (S) and the insoluble (I) fractions of Aβ42wt and
Aβ42F19D, Aβ42F19D/L34P expressing cells, probed with an antibody against GFP protein; * indicates the presence of SDS resistant oligomers, (b) GFP relative ﬂuorescence signal of
Aβ42wt and F19D, F19D/L34Pmutants in intact E. coli cells as measured by ﬂuorescence spectroscopy, (c) histogram of Aβ42wt-GFP variants showing the average values of ﬂuorescence
intensity at a wavelength of 530 nmas detected by ﬂow cytometry for 20,000 total events, (d) visualization of GFP ﬂuorescence in bacteria expressing Aβ42wt (left), Aβ42F19D (middle),
Aβ42F19D/L34P (right) by optical ﬂuorescence microscopy. Scale bar corresponds to 10 μm. All experiments correspond to 4 h after induction of protein expression.
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ture and their viability; the higher the ﬂuorescence of the variant, the
lower the proportion of dead cells (Fig. 3A). In this way, at the endpoint
of the experiment, 58% of the cells expressing Aβ42wt are dead, which
contrast with 94% of non-induced cells bearing the Aβ42wt plasmid
being viable at this time point. The percentage of dead cells decreases
to 27% and 5% for F19D and F19D/L34P variants, respectively, strongly
suggesting that aggregation properties account for the observed differ-
ences in cell viability.3.4. Relationship between Aβ42 aggregation propensity and cellular
metabolic activity
We wondered whether the toxic effects exerted by the different
Aβ42 variants could be associated to changes in the metabolic activity
of the respective cells. To this aim the metabolic state of bacterial cells
was evaluated using the 5-cyano-2,3-ditolyl tetrazolium chloride
(CTC) probe. CTC is reduced in respiring cells to a red insoluble ﬂuores-
cent formazan precipitate. As the membrane of viable cells is imperme-
able to the chargedmolecules, positively charged formazan accumulates
intracellulary and this product is quantiﬁable by FC in individual cells.
As above, in a second channel we recorded GFP ﬂuorescence emission
in such a way that dot plots of CTC vs. GFP allows to monitor both met-
abolically active cells and their GFP ﬂuorescence; only intact cells
displaying GFP ﬂuorescence and thus expressing the protein fusion
were taken into account for analysis in the case of induced cells
(Fig. 4A). The respiratory activity of induced and non-induced cells
was assessed at times corresponding to 4, 8 and 24 h after induction of
protein expression.A large majority of non-induced cells remain metabolically active for
the three variants at 4 h and 8 h, with 95–99% and 97–99% of the cells
displaying respiratory activity (Fig. 4B). After 24 h 19% and 18% of non-
induced cells are metabolically inactive for the more aggregation-prone
Aβ42wt and F19D variants, whereas this value is 7% for F19D/L34P,
which suggests that this difference might be associated to certain leaky
expression at this time point.
For induced cells, the percentage of metabolically active cells de-
creases with time for the three variants, but at any point time the pro-
portion of Aβ42wt expressing active cells is signiﬁcantly lower than
that of cells expressing the mutant forms (Fig. 4B). At the endpoint of
the experiment it is evident a correlation between the aggregation pro-
pensity of the variant and themetabolic state of the cells, being 12%, 38%
and 54% of the cells expressing Aβ42wt, F19D and F19D/L34P variants
metabolically active, respectively. It is observed again a direct relation-
ship between the mean ﬂuorescence of the cells in the culture and the
number of active cells (Fig. 4A). The toxic effect of protein aggregation
is more evident in the cell respiratory activity than in overall cell viabil-
ity, thus even if around 42% of the cells expressing Aβ42wt are alive
after 24 h, 70% of them seem to bemetabolically compromised. The per-
centage of metabolically inactive cells among those alive after 24 h is
also high for the F19D and F19D/L34P mutants, but lower than those
in Aβ42wt samples, with 48% and 43% of living cells displaying low re-
spiratory activity, respectively.
We plotted the viability andmetabolic activity for the different Aβ42
variants against time (Supplementary Fig. 1). Despite we only analyzed
three time points, it is evident that from the very beginning of the ex-
periment the ratio of cell death and loss of respiratory activity is faster
for the more aggregation-prone Aβ42wt variant. Despite the toxicity
of the double mutant is always lower than that of F19D, their effects
Fig. 3. Impact of Aβ42 variants on cell viability. (a) Viability dot plot diagrams of IP staining of E. coli expressing Aβ42wt and Aβ42F19D, Aβ42F19D/L34P mutants evaluated by ﬂow cy-
tometry, after 24 h. Non-induced Aβ42wt cells are shown as a negative control. Red ﬂuorescence corresponds to the PerCP-Cy5-A channel showing IP stained cells and Green ﬂuorescence
corresponds to FITC-A channel showing theGFP ﬂuorescence. The lower quadrants correspond to viable cells, and the upper quadrants to dead permeated cells. In the upper quadrants the
percentage of dead cells versus total cells is indicated, (b) percentage of dead cells at 4, 8 and 24 h culture, for non-induced (hatched bars) and induced (solid bars) bacteria, expressing
Aβ42wt (red) and Aβ42F19D (green), Aβ42F19D/L34P (blue) mutants as derived from ﬂow cytometry analysis of 20,000 events.
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of cell death and loss of respiratory activity for the Aβ42wt and F19D/
L34P variants appear to be rather constant along the experiment, the
toxicity of F19D seems to be exacerbated at longer incubation times, ap-
parently attaining rates comparable to that of the Aβ42wt form.3.5. Aβ42 aggregation propensity determines cell ﬁtness
In order to assess whether the aggregating properties of the different
Aβ42 variantsmay affect cell ﬁtness andhelp to explain the evolutionary
selection against aggregation-prone sequences in proteins, we grew
mixed bacterial cultures, so that cells expressing one Aβ42 variant com-
pete in the samemediumwith cells expressing another variant. After 8 h,
24 h and 48 h of competition, the DNA was puriﬁed and sequenced to
establish the variants content of the mixed culture, allowing to monitor
cell ﬁtness in a simple manner; an approach previously used to address
the role of aggregation gatekeepers in bacterial ﬁtness [33]. The
results from these assays are shown in Table 1 (each competition was
independently repeated 5 times). Independently of the pair-wise com-
bination, the Sanger sequencing only turned up a single sequence in
each individual replica, indicating the presence of a dominant variant
in the competition experiment. For each pair-wise competition experi-
ment we considered that one variant competed the other only if all rep-
licates rendered the same sequence. After 8 h the F19D/L34P variant
already competes the Aβ42wt sequence, but it is not able to displace
the F19D mutant. In a similar manner, the presence of the Aβ42wt
sequence is still detectable in Aβ42wtF19D competition experiments at
this time point. However, we observed that at longer incubation times
(24 and 48 h) and independently of the competing pair, the lessaggregating Aβ42 variant always dominates the competition, indicating
thus that, in this model system, cell ﬁtness is linked to aggregation
propensity.3.6. Chemical chaperones modulate the intracellular aggregation rate of
Aβ42 peptide
Osmolytes are present in the intracellular milieu of cells in a wide
range of organisms to counterbalance stress conditions that might desta-
bilize proteins, acting thus as chemical chaperones by preventing their
misfolding and subsequent aggregation [34,35]. We analyzed if Glycerol,
Betaine, Trehalose, TMAO and Proline had any effect on the aggregation
of the Aβ42wt-GFP fusion by monitoring the ﬂuorescence of induced in-
tact cells grown in their absence and presence by spectroﬂuorimetry.
Among the assayed osmolytes only TMAO and Pro were able to increase
signiﬁcantly GFP ﬂuorescence (Fig. 5A). We fractionated the cells and an-
alyzed whether this increase in ﬂuorescence is linked to a higher level of
soluble protein by western blotting. As it can be seen in Fig. 5B, the pres-
ence of osmolytes does not have any noticeable effect on the distribution
of the protein between the soluble and insoluble fractions, remaining in all
cases essentially as insoluble aggregates, thepresence of SDS resistant spe-
cies being detectable in all cases.We conﬁrmed byﬂuorescencemicrosco-
py that all the GFP ﬂuorescence signal was located at the IBs in the cell
poles (Fig. 5C). However, the IBs formed in the presence of osmolytes
were signiﬁcantly more ﬂuorescent that those of cells grown in their ab-
sence. This implies that the effect of the osmolytes emulates that of the
F19D mutation, decreasing the aggregation rate of the Aβ moiety and
thus allowing the GFP domain to fold signiﬁcantly before aggregation oc-
curs [20].
Fig. 4. Evaluation of the respiratory activity of cells expressing Aβ42 variants. (a) Dot plot diagrams of metabolic activity evaluated by ﬂow cytometry of bacteria expressing Aβ42wt,
Aβ42F19D and Aβ42F19D/L34P variants cultured for 24 h. Bacteria were stained with 5 mM CTC and analyzed using 670 nm longpass ﬁlter. Red ﬂuorescence corresponds to PerCP-
Cy5-A channel showing CTC signal, and Green ﬂuorescence corresponds to FITC-A channel showing the GFP ﬂuorescence. Aβ42wt non-induced and not CTC stained cells were used to
set the red ﬂuorescence threshold, (b) percentage of metabolically inactive cells at 4, 8 and 24 h culture, for non-induced (hatched bars) and induced (solid bars) bacteria, expressing
Aβ42wt (red) and Aβ42F19D (green), Aβ42F19D/L34P (blue) mutants as derived from ﬂow cytometry analysis of 20,000 events.
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If we assume that the reducedmetabolic damage caused by the F19D
mutant, relative to Aβ42wt, results from a lower deposition rate, one
should expect that TMAO and Pro would exert a similar protective ef-
fect. To address this point we used IP, to evaluate viability, and the
CTC redox dye, to monitor respiratory activity, in cells grown in the ab-
sence and presence of osmolytes by FC 8 h and 24 h post-induction,
where differences amongAβ42 variants aremore evident. In our assays,
TMAO turned to be moderately cytotoxic, reducing the viability of non-
induced cells around 15% at a time equivalent to 24 h after induction,
relative to cells grown in the absence of the compound. Thus, despite
this effectwas not evident at the 8 h,we discarded this osmolyte for fur-
ther analysis. In contrast, in agreement with previous reports [36], Pro
didn't exhibit any detectable cytotoxicity for non-induced cells (data
not shown).
As shown in Fig. 6, at both time points, Pro is able to partially restore
themetabolic activity of cells expressing the Aβ42wt form. Although 24
h after induction the proportion of metabolically active bacteria grownTable 1
Results from pairwise clonal selection experiment.
Cultures were simultaneously co-inoculated with bacteria containing the different Aβ42
variants constructs in all possible binary combinations. After the indicated period of com-
petitive growth, the plasmids were extracted, sequenced and compared with those ex-
tracted from individual cultures of the three variants. Analyses were repeated ﬁve times.
The table shows the different Aβ42 constructs detected for each pairwise growth compe-
tition experiment.
Competing variants 8 h 24 h 48 h
wt and F19D wt–F19D F19D F19D
wt and F19D/L34P F19D/L34P F19D/L34P F19D/L34P
F19D and F19D/L34P F19D–F19D/L34P F19D/L34P F19D/L34Pin the presence Pro is still much lower than those of control non-
induced cells, it is 2.7 times higher than the proportion of active cells
in the absence of the osmoprotectant (Fig. 6A and B). The same effect
is observed for induced cells expressing the two mutants in the pres-
ence of Pro, with increases in the proportion of active cells at 24 h of
1.6 and 1.3 fold for the F19D and F19D/L34P variants, respectively, rela-
tive to the same cells grown in the absence of osmolyte.
Pro is also able to increase the viability of induced cells expressing
any of the three proteins (Fig. 6C); but this effect is only signiﬁcant at
the 8 h. At this time point, Pro reduces the proportion of dead cells in
cultures expressing the Aβ42wt form from 18% to 7%. In the case of
the two mutants this beneﬁcial effect is also detectable, but since the
proportion of viable cells in the absence of the osmolyte is already
higher than 97% in both cases, the total impact in viability is rather
low. At the 24 h, despite the effect of the osmolyte is still detectable,
the differences in viability between cells grown in the absence and pres-
ence of proline are rather small, being linked to the aggregation propen-
sity of the particular variant, which at this time point bypassmost of the
protective role of the osmolyte against cell death (Fig. 6C).
4. Discussion
The hypothesis that, in addition to protein function, protein
misfolding and aggregation can act as a strong constraint on coding se-
quences evolution is attracting increasing interest. The misfolding and
aggregation hypothesis is supported by computational simulations
[11] as well as by the observed inverse correlation between expres-
sion/abundance protein levels and the theoretical intrinsic aggregation
propensities of sequences [7,37,38]. However, the experimental evi-
dence supporting this view is still scarce, mainly because the evaluation
of the ﬁtness cost caused by protein misfolding and aggregation has
been traditionally difﬁcult. Moreover, the few studies that have
Fig. 5. Intracellular aggregation of Aβ42wt in the presence of osmolytes. (a) GFP relative ﬂuorescence signal of bacteria expressing Aβ42wt treated with 0.5 M proline and 0.5 M TMAO
analyzed by ﬂuorescence spectroscopy, (b) immunoblot analysis of Aβ42wt total lysates (T), soluble (S) and insoluble (I) fractions from cultures treated with 0.5 M proline and 0.5 M
TMAO, and probed with an antibody against GFP protein; * indicates the presence of SDS resistant oligomers, (c) visualization of GFP ﬂuorescence in bacteria expressing Aβ42wt
grown in the absence (left), and presence of 0.5 M proline (middle) and 0.5 M TMAO (right) by optical ﬂuorescence microscopy. Scale bar corresponds to 10 μm. All experiments corre-
spond to 4 h after induction of protein expression.
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sults. In this way, the expression of wild type β-galactosidase in E. coli
resulted in a large decrease in growth rate, whereas misfolded mutants
often had less impact in ﬁtness, which led the authors to conclude that
misfolded proteins are nomore toxic thanwild type proteins in bacteria
[39]. Contrary to this ﬁnding, when folded and misfolded forms of the
N-terminal domain of λ-repressor were expressed in E. coli, only the
misfolded variant elicited a detectable cellular response [40]. Similarly,
the ﬁtness cost of expressing misfolded variants of the yellow ﬂuores-
cent and URA3 proteins in S. cerevisiae turned to be higher than those
of expressing the wild type forms [16].
Here we exploit the discovery that intracellular protein aggregates
impact bacterial ﬁtness [19,20], together with the possibility of re-
designing their in vivo aggregative properties with a reduced number
of sequential changes, to investigate the purifying role of aggregation
in the evolution of protein sequences. We expressed a single gratuitous
aggregation-prone protein to discard that the observed phenotypes
might also respond to a loss of function effect. In addition, since Aβ42
peptide is essentially disordered we also skipped the inﬂuence of
pointmutations on thermodynamic stability to focus on the sequential-
ly encoded aggregation propensity.
In our system, in terms of viability, the cost associated to protein ag-
gregation is signiﬁcantly higher than that associatedwith the gratuitous
expression of the Aβ42-GFP fusion. The reduction in cellular viability
caused by the insoluble Aβ42wt after 24 h is ~50%, relative to that of
non-induced cells. Reduction of the aggregation propensity by the
F19D point mutation increases viability by ~30% and introducing the
L34P substitution an additional ~20%, attaining viability values very
close to those of non-induced cells (~95%). Also at shorter times, 4 hand 8 h, the viability of cells expressing the more soluble variant are
equivalent to those of non-induced cells bearing the same plasmid,
whereas differences in viability between cells expressing the most and
less aggregating variants are evident at any time point.
The impact of gratuitous expression on cell respiratory activity
seems to be more important, since we observe a signiﬁcantly higher
proportion of metabolically inactive cells in bacteria expressing the
more soluble F19D/L34P variant relative to non induced cells at any
time point. However, it is likely that a part of this metabolic cost
might respond to certain degree of toxicity of this variant, since despite
its lower aggregation propensity still ~25% of the protein forms insolu-
ble aggregates. This view is supported by the fact that the presence of
Pro increases the number of active cells expressing the F19D/L34P var-
iants in a 20%. In any case, because all variants are expressed at equiva-
lent levels, the large differences in metabolic activity between mutants
should respond to their speciﬁc intrinsic properties, clearly correlating
with their predicted and in vivo aggregation propensities, as reﬂected
by cell GFP ﬂuorescence levels, at any time point. Moreover, the differ-
ence in the proportion of metabolically active cells between the
Aβ42wt and F19D/L34P variants always exceeds that observed between
the double mutant and non-induced cells.
In contrast to previous results using the lac operon in E. coli [39], our
data indicate that the cost of gratuitous protein expression is both in the
process and in the products.We are aware that the relative contribution
of these factors might depend on the unique properties of individual
proteins such as the toxicity of the misfolded/aggregated species and
might differ among organisms. However, comparison of these costs in
our model system indicate that the aggregation toxicity cost is a signif-
icant contributor to cell ﬁtness in bacteria, explaining why the most
Fig. 6. Effect of proline on the viability and respiratory activity of cells expressing Aβ42 variants. (a) Dot plot diagrams of metabolic activity evaluated by ﬂow cytometry of bacteria ex-
pressing Aβ42wt (left), and treated with 0.5 M proline (right) for 24 h. Red ﬂuorescence corresponds to the PerCP-Cy5-A channel showing CTC stained cells and Green ﬂuorescence cor-
responds to FITC-A channel showing the GFP ﬂuorescence. In the ﬁgure upper quadrants indicate the percentage of metabolic active cells versus total cells. (b) Representation of the
percentage of metabolic inactive cells of bacteria expressing Aβ42wt, and Aβ42F19D, Aβ42F19D/L34P variants, in the absence (hatched bars) and presence (solid bars) of 0.5 M proline
at 4, 8 and 24 h postinduction. (c) Representation of the percentage of IP permeable dead cells expressing Aβ42wt, and Aβ42F19D, Aβ42F19D/L34P variants, in the absence (hatched bars)
and presence (solid bars) of 0.5 M proline at 4, 8 and 24 h postinduction. In (b) and (c) data were derived from ﬂow cytometry analysis of 20,000 events.
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in pairwise growth competition experiments and supporting selection
against toxic protein misfolding as an important factor determining
the rate of amino acid substitution in bacterial proteins, where damage
might pass from one generation to the next. These data are in excellent
agreement with those in a recent study by Beerten and co-workers in
which they address the role of aggregation gatekeepers on protein
homeostasis and bacterial ﬁtness by ﬂanking an aggregation-prone
sequence with different residues [33]. As in our case, the most
aggregation-prone variants resulted in the highest ﬁtness cost, indicat-
ing that toxic protein misfolding is largely independent of the protein
model.
Importantly, cell ﬁtness is sensitive to the aggregation rate of the
Aβ42-GFP variants rather than to the ﬁnal soluble/insoluble state of
the protein, as exempliﬁed by the different impact on cell viability and
respiratory activity of the Aβ42wt and F19D forms, both essentially in-
soluble at equilibrium. In a previous study, we demonstrated that in
contrast to Aβ42wt, which aggregates immediately after synthesis, the
F19D variant remains soluble in the cytoplasm for long time before
the ﬁrst visible aggregates appear at the poles of the cell [20]. This
would explain why the F19D and the F19D/L34P variants have essen-
tially the same low impact on cell viability and metabolic activity at
early stages and why F19D becomes signiﬁcantly more toxic towards
the end of the experiment. This implies that, in our model system,
they are the aggregated or the aggregating species that exert the toxic
effect, with a reduced impact in cell ﬁtness of the soluble species, evenif they can represent more than 10% of the total cell protein in the
case of the F19D/L34P variant. It has been suggested that the localization
of misfolded proteins to IBsmight be protective by preventing jamming
of the cytosol and relieving the effects associated to unspeciﬁc binding
to other cellular components. Our results suggest instead that their for-
mation or their presence is inherently toxic, independently if the delete-
rious effect is exerted by themature aggregate or by smaller assemblies
in the aggregative pathway. Our data indicate that under protein aggre-
gation challenge, the cellular metabolic state is a better indicator of
proteotoxicity than cell death. It has been recently shown that distur-
bance of proteostasis by protein aggregates promotes metabolic arrest
through a decrease in protein synthesis capacity [41,42]. This metabolic
effect might constitute a cellular mechanism to adapt the bulk of new-
born proteins to unfavorable aggregation-promoting conditions, but in
any case endorse cells with a ﬁtness disadvantage relative to cells ex-
pressing less aggregation-prone protein variants. In fact, in our model
system continuous recombinant expression makes this strategy in
vain, leading cells eventually to die. In any case, we show that reducing
the aggregation rate delays the population of the toxic conformers and
reduce the cell ﬁtness cost, at least during the ﬁrst generations. This is
exactly the effect exerted by proline, which would act destabilizing the
initial soluble oligomeric species therefore delaying, but not impeding,
the growth of intracellular aggregates [36,43]. A mechanism of action
that resembles that of molecular chaperones, whose overexpression in
our model system cannot impede the formation of aggregates by the
Aβ42wt and the F19D variants, but reduces in both cases their in vivo
874 S. Navarro et al. / Biochimica et Biophysica Acta 1843 (2014) 866–874aggregation rates [20]. This osmolyte mediated modulation of aggrega-
tion propensities may allow the evolution of new protein sequences
that in their absencewould be rapidly purged out due to its negative im-
pact on cell ﬁtness, contributing thus to genetic buffering [34]. Overall,
we provide consistent and rigorous new experimental data in favor of
a dominant role of protein aggregation in the evolution of the protein
sequences.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.01.020.
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